Engineering tumor-targeted gadolinium hexanedione nanoparticles for potential application in neutron capture therapy

Bioconjugate Chemistry

Volumn 13, Issue 6, 2002, Pages 1328-1335

  Oyewumi, Moses O ^a   Mumper, Russell J ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CULTURE; EMULSIFICATION; GADOLINIUM; GEL PERMEATION CHROMATOGRAPHY; LIGANDS; MICROEMULSIONS; MOLECULAR BIOLOGY; ORGANIC ACIDS; POLYETHYLENE GLYCOLS; SYNTHESIS (CHEMICAL); TUMORS;

COATED NANOPARTICLES; FOLATE LIGANDS; FOLATE RECEPTOR; FOLATES; FOLIC ACIDS; GADOLINIA; NANOPARTICLE UPTAKES; NEUTRON CAPTURE THERAPY; OIL-IN-WATER; SYNTHESISED;

NANOPARTICLES;

EID: 0036861756     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc025560x     Document Type: Article

References (38)

1. Akine, Y., Tokita, T., Matsumoto, H., Oyama, S., Egawa, O., and Aizawa, O. (1990) Radiation effect of gadolinium-neutron capture reactions on survival of Chinese hamster cells. Strahlenther. Onkol. 166, 831-833.
2. Atkinson, S. F., Bettinger, T., Seymour, L. W., Behr, J., and Ward, C. (2001) Conjugation of folate via gelonin carbohydrate residues retains ribososmal-inactivating properties of the toxin and permits targeting to folate receptor positive cells. J. Biol. Chem. 276, 27930-27935.
3. Bally, M. B., Masin, D., Nayar, R., Cullis, P. R., and Mayer, L. D. (1994) Transfer of liposomal drug carriers from blood to the peritoneal cavity of normal and ascitic tumor-bearing mice. Cancer Chemother. Pharmacol. 34, 137-146.
4. Barth, R. F., and Soloway, A. H. (1994) Boron neutron capture therapy of primary and metastatic brain tumors. Mol. Chem. Neuropathol. 21, 139-154.
5. Bernard, J. A. (1995) Procedures for Implementation of MIT program on Neutron capture therapy. Trans Am. Nucl. Soc. 72, 114.
6. Chen, W., Mehta, S. C., and Lu, R. D. (1997) Selective boron drug delivery to brain tumors for neutron capture therapy. Adv. Drug Deliv. Rev. 26, 231-247.
7. Davda, J., Labhasetwar, V., (2001) Characterization of nanoparticles uptake by endothelial cells. Int. J. Pharm. 233, 51-59.
8. Desai, M. P., Labhasetwar, V., Amidon, G. L., and Levy, R. J. (1996) Gastrointestinal uptake of biodegradable microparticles in Caco-2 cells is size dependent. Pharm. Res. 14, 1568-1573.
9. Goren, D., Horowitz, A. T., Tzemach, D., Tarshish, M. M., Zalipsky, S., and Gabizon, A. (2000) Nuclear delivery of doxorubicin via folate-targeted liposomes with bypass of multidrug-resistance efflux pump. Clin. Cancer Res. 6, 1949-1957.
10. Hassan, E. E., Parish, C. R., and Gallo, M. J. (1992) Optimized formulation of magnetic chitosan microparticles containing anticancer agent, oxantrazole. Pharm. Res. 9, 390-397.
11. Hobbs, S. K., Monsky, W. L., Yuan, F., Roberts, W. G., Griffith, L., Torchilin, V. P., and Jain, R. K. (1998) Regulation of transport pathways in tumor vessels: Role of tumor type and microenvironment. Proc. Natl. Acad. Sci. 95, 4607-1612.
12. Holm, J., Hansen, S., and Lyngbye, J. (1981) High-affinity binding of folate to a serum protein in chronic myelogenous leukemia: Effect of binder concentration, pH and temperature. Clin. Chem. 27, 316-318.
13. Holm, J., Hansen, S., and Lyngbye, J. (1983) High-affinity folate binding in leukocyte lysate from normal subjects: Effect of concentration of binding protein, temperature and pH. Acta Heamatol. 70, 269-272.
14. Jain, R. K. (1997) Delivery of molecular and cellular medicine to solid tumors. Adv. Drug Deliv. Rev. 26, 71-90.
15. Jono, K., Ichikawa, H., Fujioka, K., Fukumori, Y., Akine, Y., and Tokuuye, K. (1999) Preparation of lecithin microcapsules by a dilution method using the wuster process for intraaterial administration in gadolinium neutron capture therapy. Chem. Pharm. Bull. 47, 54-63.
16. Kamen, B. A., and Caston, J. D. (1986) Properties of a folate binding protein (FBP) isolated from porcine kidney. Biochem. Pharmacol. 35, 2323-2329.
17. Kreuter, J. (1995) Nanoparticles as adjuvants for vaccines. Pharm. Biotechnol. 6, 463-472.
18. Lee, R. J., and Low, P. S. (1994) Delivery of liposomes into cultured KB cells via folate receptor-mediated endocytosis. J. Biol. Chem. 269, 3198-3204.
19. Lee, R. J., and Low P. S. (1995) Folate-mediated tumor cell targeting of liposome-entrapped doxorubicin in-vitro. Biochim. Biophys. Acta. 1233, 134-144.
20. Lee, R. J., and Huang, L. (1996) Folate-targeted, anionic liposome-entrapped polylysine-condensed DNA for tumor cell-specific gene transfer. J. Biol. Chem. 271, 8481-8487.
21. Martin, R. F., D'Cunha, G., Pardee, M., and Allen, B. J. (1988) Induction of double-strand breaks following neutron capture by DNA-bound 157Gd. Int. J. Radiat. Biol. 54, 205-208.
22. Matsumoto, T. (1992) Transport calculations of depth-dose distributions for gadolinium neutron capture therapy. Phys. Med. Biol. 37, 155-162.
23. Mehta, S. C., and Lu, R. D. (1996) Targeted drug delivery for boron neutron capture therapy. Pharm. Res. 13, 345-351.
24. Miyamoto, M., Hirano, K., Ichikawa, H., Fukumori, Y., Akine, Y., and Tokuuye, K. (1999) Biodistribution of gadolinium incorporated in lipid emulsions intraperitoneally administered for neutron capture therapy with tumor-bearing hamsters. Biol. Pharm. Bull. 12, 1331-1340.
25. Morel, S., Terreno, E., Ugazio, E., Aime, S., and Gasco, M. R. (1998) NMR relaxometric investigations of solid lipid nanoparticles (SLN) containing gadolinium (III) complexes. Eur. J. Pharm. Biopharm. 45, 157-163.
26. Mumper, R. J., and Jay, M. (1992) The formation and stability of lanthanide complexes and their encapsulation into polymeric microspheres. J. Physical Chem. 33, 398-402.
27. Oyewumi, M. O., and Mumper, R. J. (2001) Microemulsions as templates to engineer cell specific nanoparticles. Proc. Int. Symp. Controlled Release Bioact. Mater. 28, 7179.
28. Oyewumi, M. O., and Mumper, R. J. (2002) Gadolinium-loaded nanoparticles engineered from microemulsions templates. Drug. Dev. Ind. Pharm. 28, 317-328.
29. Pan, X. Q., Wang, H., Shukla, S., Sekido, M., Adams, D., Tjarks, W., Barth, R. F., and Lee, R. J. (2002) Boron-containing folate receptor-targeted liposomes as potential delivery agents for neutron capture therapy. Bioconjugate Chem. 13, 435-442.
30. Reisfeld, R., and Biron, E. (1970) Determination of gadolinium in sodium borate glasses. Talanta 17, 105-108.
31. Shih, J., and Brugger, R. M. (1992) Gadolinium as a neutron capture agent. Med. Phys. 3, 733-744.
32. Shikata, F., Tokumitsu, H., Ichikawa, H., and Fukumori, Y. (2002) In vitro cellular accumulation of gadolinium incorporated into chitosan nanoparticles designed for neutron-capture therapy of cancer. Eur. J. Pharm. Biopharm. 53, 57-63.
33. Tokumitsu, H., Ichikawa, H., and Fukumori, Y. (1999) Chitosan-gadopentetic acid complex nanoparticles for gadolinium neutron capture therapy of cancer: Preparation by novel emulsion droplet coalescence technique and characterization. Pharm. Res. 16, 1830-1835.
34. Tokumitsu, H., Hiratsuka, J., Sakurai, Y., Kobayashi, T., Ichikawa, H., and Fukumori, Y. (2000) Gadolinium neutron-capture therapy using novel gadopentetic acid-chitosan complex nanoparticles: In vivo growth suppression of experimental melanoma solid tumor. Cancer Lett. 150, 177-182.
35. Tokuuye, N., Tokita, Y., Akine, H., Nakayama, Y., Sakurai, T., Kobayashi, K. K. (2000) Comparison of radiation effects of gadolinium and boron neutron capture reactions. Strachlenther. Onkol. 176, 81-83.
36. Wang, S., and Low, P. S. (1998) Folate-mediated targeting of antineoplastic drugs, imaging agents and nucleic acids to cancer cells. J. Controlled Release 53, 39-48.
37. Weitman, S. D., Lark, R. H., Coney, L. R., Fort, D. W., Frasca, V., Zurawski, V. R., and Kamen, B. A. (1992) Distribution of the folate receptor GP38 in normal and malignant cell lines and tissues. Cancer Res. 52, 3396-3401.
38. Wu, N. Z., Da, D., Rudoll, T. L., Needham, D., Whorton, A. R., and Dewhisrt, M. W. (1993) Increased microvascular permeability contributes to preferentially accumulation of shealth liposomes in tumor tissue. Cancer Res. 53, 3765-3770.